These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 8899688)

  • 1. The applicability of in vitro hepatic models in pharmacology.
    Riché C
    Methods Find Exp Clin Pharmacol; 1996; 18 Suppl B():21-2. PubMed ID: 8899688
    [No Abstract]   [Full Text] [Related]  

  • 2. Diphenylhydantoin stimulation of various pathways of hepatic microsomal drug metabolism in rabbits.
    Gut I; Becker BA
    Acta Univ Carol Med (Praha); 1980; 26(1-2):105-14. PubMed ID: 7315667
    [No Abstract]   [Full Text] [Related]  

  • 3. Cell culture-based models for intestinal permeability: a critique.
    Balimane PV; Chong S
    Drug Discov Today; 2005 Mar; 10(5):335-43. PubMed ID: 15749282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative in vitro and in vivo drug metabolism in major and minor food-producing species.
    Dalvi RR
    Vet Hum Toxicol; 1988; 30 Suppl 1():22-5. PubMed ID: 3212938
    [No Abstract]   [Full Text] [Related]  

  • 5. Binding of drugs to hepatic microsomes: comment and assessment of current prediction methodology with recommendation for improvement.
    Hallifax D; Houston JB
    Drug Metab Dispos; 2006 Apr; 34(4):724-6; author reply 727. PubMed ID: 16552024
    [No Abstract]   [Full Text] [Related]  

  • 6. [Advances and related issues in the use of in vitro methods to predict metabolic clearance rate of new drugs].
    Zhang Q; Wang GJ
    Yao Xue Xue Bao; 2007 Oct; 42(10):1023-8. PubMed ID: 18229605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applications of epithelial cell culture in studies of drug transport.
    Tavelin S; Gråsjö J; Taipalensuu J; Ocklind G; Artursson P
    Methods Mol Biol; 2002; 188():233-72. PubMed ID: 11987548
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of age-related changes in hepatic drug metabolism in miniature swine.
    Peggins JO; Shipley LA; Weiner M
    Drug Metab Dispos; 1984; 12(3):379-81. PubMed ID: 6145568
    [No Abstract]   [Full Text] [Related]  

  • 9. [Influence of uremia on glucuronization of drugs in rat liver microsomes].
    Leber HW; Gleumes A; Schütterle G
    Verh Dtsch Ges Inn Med; 1973; 79():711-3. PubMed ID: 4789956
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term expression of differentiated functions in hepatocytes cultured in three-dimensional collagen matrix.
    Gómez-Lechón MJ; Jover R; Donato T; Ponsoda X; Rodriguez C; Stenzel KG; Klocke R; Paul D; Guillén I; Bort R; Castell JV
    J Cell Physiol; 1998 Dec; 177(4):553-62. PubMed ID: 10092208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of epithelial cell culture in drug transport in the respiratory tract.
    Shen J; Lee VH
    Methods Mol Biol; 2002; 188():217-32. PubMed ID: 11987547
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of structural modifications on drug-hepatic microsomal interactions [proceedings].
    Houston JB; Al-Gailany KA; Bridges JW
    J Pharm Pharmacol; 1977 Dec; 29 Suppl():76P. PubMed ID: 22710
    [No Abstract]   [Full Text] [Related]  

  • 13. The prediction of human clearance from hepatic microsomal metabolism data.
    Obach RS
    Curr Opin Drug Discov Devel; 2001 Jan; 4(1):36-44. PubMed ID: 11727321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Catabolism of drugs through oxidation].
    Staudinger H; Degkwitz E; Ullrich V
    Med Welt; 1969 Dec; 51():2747-54. PubMed ID: 5371539
    [No Abstract]   [Full Text] [Related]  

  • 15. Prediction of human hepatic clearance from in vivo animal experiments and in vitro metabolic studies with liver microsomes from animals and humans.
    Naritomi Y; Terashita S; Kimura S; Suzuki A; Kagayama A; Sugiyama Y
    Drug Metab Dispos; 2001 Oct; 29(10):1316-24. PubMed ID: 11560875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of culture time on the expression of drug-metabolizing enzymes in primary human hepatocytes and hepatoma cell line HepG2.
    Wilkening S; Bader A
    J Biochem Mol Toxicol; 2003; 17(4):207-13. PubMed ID: 12898644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of drug metabolizing enzymes: a survey of in vitro methodologies and interpretations used in the pharmaceutical industry--do they comply with FDA recommendations?
    Hewitt NJ; de Kanter R; LeCluyse E
    Chem Biol Interact; 2007 May; 168(1):51-65. PubMed ID: 17239835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The chimpanzee (Pan troglodytes) as a pharmacokinetic model for selection of drug candidates: model characterization and application.
    Wong H; Grossman SJ; Bai SA; Diamond S; Wright MR; Grace JE; Qian M; He K; Yeleswaram K; Christ DD
    Drug Metab Dispos; 2004 Dec; 32(12):1359-69. PubMed ID: 15333515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of human pharmacokinetics--evaluation of methods for prediction of hepatic metabolic clearance.
    Fagerholm U
    J Pharm Pharmacol; 2007 Jun; 59(6):803-28. PubMed ID: 17637173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoprotective activity of boldine: modulation of drug-metabolizing enzymes.
    Kubínová R; Machala M; Minksová K; Neca J; Suchý V
    Pharmazie; 2001 Mar; 56(3):242-3. PubMed ID: 11265593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.